[Importance of bFGF ("basic fibroblast growth factor") for diagnosis and treatment of hemangiomas].

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Annales de dermatologie et de vénéréologie

• Publication date

  1998-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 9747277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?

  1997cited by this paper
• Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas.

  1997cited by this paper
• Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas.

  1997cited by this paper
• Definition of two angiogenic pathways by distinct alpha v integrins.

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

  1995cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.

  1995cited by this paper
• Cellular markers that distinguish the phases of hemangioma during infancy and childhood.

  1994cited by this paper
• Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers.

  1994cited by this paper
• Increased level of basic fibroblast growth factor (bFGF) in sera of patients with malignant tumors.

  1993cited by this paper
• Basic fibroblast growth factor secreted by an animal tumor is detectable in urine.

  1993cited by this paper
• The Current Management of Vascular Birthmarks

  1993cited by this paper
• Interferon alfa‐2a therapy for life‐threatening hemangiomas of infancy

  1992cited by this paper
• [Cervico-cephalic hemangiomas and vascular malformations. Histopathological appearance and classification].

  1992cited by this paper
• Recent developments in the cell biology of basic fibroblast growth factor

  1989cited by this paper
• Hemangiomas and Vascular Malformations in Infants and Children: A Classification Based on Endothelial Characteristics

  1982cited by this paper

• Importance of Determining Vascular Endothelial Growth Factor Serum Levels in Children with Infantile Hemangioma

  2023cites this paper
• Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma.

  2021cites this paper
• Cavernous Hemangiomas of the Temporal Bone

  2020cites this paper
• Circulating Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Infantile Hemangioma Versus Vascular Malformations

  2018cites this paper
• The expression and function of miR-424 in infantile skin hemangioma and its mechanism

  2017cites this paper
• Serum Basic Fibroblastic Growth Factor Levels in Children with Infantile Hemangioma

  2016cites this paper
• A Case of Kasabach-Merritt Syndrome Successfully Treated with Interferon-alpha 2b and Propranolol

  2015cites this paper
• Effect of propranolol on the expression of growth factors and apoptotic factors related to infantile hemangiomas

  2015influential citation
• Kasabach–Merritt phenomenon in an adult man with a tufted angioma and cirrhosis responding to radiation, bevacizumab, and prednisone

  2014cites this paper
• Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas.

  2013cites this paper
• [Infantile vascular tumors].

  2010cites this paper
• Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth.

  2010cites this paper
• Serum levels of basic fibroblastic growth factor (bFGF) in children with vascular anomalies: Another insight into endothelial growth.

  2010cites this paper
• Biomarkers: important clues to the pathogenesis of infantile haemangioma and their clinical significance.

  2010cites this paper
• Intramuscular hemangioma presenting with periosteal reaction: report of two cases and review

  2009cites this paper
• Head and neck vascular anomalies in children.

  2009cites this paper
• A Phase II, Open‐Label Study of the Efficacy and Safety of Imiquimod in the Treatment of Superficial and Mixed Infantile Hemangioma

  2009cites this paper
• [Intralesional corticosteroid therapy in infantile hemangiomas].

  2009cites this paper
• Effects of interferon‐α2b on keloid treatment with triamcinolone acetonide intralesional injection

  2008cites this paper
• The Molecular Pathogenesis of Haemangioma

  2008cites this paper
• The potential efficacy of omega-3 fatty acids as anti-angiogenic agents in benign vascular tumors of infancy.

  2006cites this paper
• IFN-alpha1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas.

  2006cites this paper
• IFN-α1,8 Inhibits Tumor-Induced Angiogenesis in Murine Angiosarcomas

  2006cites this paper
• [State of the art of classification, diagnostics and therapy for cervicofacial hemangiomas and vascular malformations].

  2006cites this paper
• Les hémangiomes cutanés : aspects cliniques

  2006cites this paper
• Angiogenetische Faktoren in Plasma und Urin bei Kindern mit Hämangiomen

  2005influential citation
• [Vincristine treatment for function- and life-threatening infantile hemangioma].

  2004cites this paper
• Traitement par vincristine des hémangiomes graves du nourrisson

  2004cites this paper
• Panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib

  2003cites this paper
• Optimal Treatment of Vascular Birthmarks

  2003cites this paper
• Estudo crítico dos resultados obtidos no tratamento dos hemangiomas cutâneos cervicofaciais

  2003cites this paper
• Life-threatening hemorrhage from a vulvar hemangioma.

  2002cites this paper
• Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review

  2002cites this paper
• Kasabach–merritt syndrome: pathogenesis and management

  2001cites this paper
• Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck

  2001cites this paper
• Regression of Infancy Hemangiomas with Recombinant IFN-α2b

  2001cites this paper
• Regression of infancy hemangiomas with recombinant IFN-alpha 2b.

  2001cites this paper
• Kasabach-Merritt syndrome: pathogenesis and management.

  2001cites this paper
• Vascular anomalies at the dawn of a new millennium

  2000cites this paper
• Les angiomes de l'enfant à un tournant dans leur compréhension et dans leur prise en charge

  1999cites this paper
• [Angiomas in children at a turning point of understanding and management].

  1999cites this paper
• [Angiomas and major tissue dysplasias. Pathogenic origins and management].

  1999cites this paper
• Angiomes et dysplasies tissulaires majeures Conceptions pathogéniques actuelles et prise en charge

  1999cites this paper